BIIB Operating Cash Flow (Statement)

Biogen · Operating Cash Flow (Statement)

BIIB logo

BIIB Operating Cash Flow (Statement)

Latest reported$448.90M
BIIB Quarterly Cash from Operations (-$200.00K → $448.90M)
High-resolution chart · PNG

BIIB operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
448,900,000
645,500,000
511,900,000
1,272,500,000
160,900,000
259,300,000
760,900,000
935,600,000
625,800,000
553,200,000
12,500,000
592,400,000
487,000,000
455,300,000
-175,000,000
661,000,000
736,500,000
161,800,000
838,300,000
805,300,000
1,227,300,000
769,000,000
-367,100,000
1,181,100,000
1,948,500,000
1,467,300,000
1,960,200,000
1,694,900,000
1,964,000,000
1,459,500,000
1,895,400,000
1,735,900,000
1,099,300,000
1,457,100,000
1,518,300,000
1,628,300,000
1,169,200,000
235,200,000
1,576,600,000
986,600,000
995,800,000
963,400,000
1,040,395,000
895,448,000
1,047,220,000
733,037,000
932,863,000
914,033,000
990,593,000
104,626,000
869,005,000
671,922,000
625,212,000
178,939,000
507,907,000
541,784,000
635,581,000
194,625,000
473,974,000
570,523,000
429,666,000
253,578,000
431,056,000
428,241,000
428,481,000
336,895,000
282,172,000
263,425,000
228,551,000
300,750,000
409,292,000
512,193,000
276,022,000
366,985,000
345,862,000
210,426,000
202,018,000
262,329,000
241,805,000
259,838,000
183,372,000
156,253,000
274,740,000
173,095,000
228,782,000
212,886,000
191,561,000
178,909,000
159,555,000
197,961,000
67,123,000
97,851,000
47,068,000
76,047,000
99,479,000
66,700,000
39,569,000
61,329,000
57,054,000
87,085,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.